Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1988 Mar;93(3):702–714. doi: 10.1111/j.1476-5381.1988.tb10329.x

Electrical and mechanical properties of the capsular smooth muscles of the rabbit prostate in relation to the actions of the alpha 1-adrenoceptor blocker, YM-12617.

N Seki 1, E Nishiye 1, T Itoh 1, H Suzuki 1, H Kuriyama 1
PMCID: PMC1853834  PMID: 2897221

Abstract

1. Electrical and mechanical properties of smooth muscle cells of the rabbit prostate capsule and the actions of the alpha 1-adrenoceptor blocker, YM-12617, were investigated using microelectrode and isometric tension recording methods. 2. The capsular muscles comprised thick and thin muscle bundles. In the former, noradrenaline (NA; 0.1-10 microM) provoked the phasic and tonic mechanical responses, with twitch contractions superimposed on the tonic response. YM-12617, in concentrations over 1 nM inhibited the contraction evoked by any given concentration of NA. Yohimbine (up to 10 microM) slightly inhibited the NA-induced contraction whilst clonidine (up to 10 microM) and acetylcholine (ACh; up to 10 microM) produced no mechanical response. 3. In thin muscle bundles, NA (0.1-10 microM) produced a contraction but the phasic response was small and the tonic response was negligible. These changes were blocked by YM-12617. In contrast, ACh (0.1-10 microM) produced atropine-sensitive, large phasic and tonic responses similar to those observed on application of NA to thick muscle bundles. 4. In thin and thick muscle bundles, the mean resting membrane potentials were -54 and -56 mV, respectively, values which were not statistically different. However, in thick muscle bundles, NA (over 0.1 microM) depolarized the membrane in a concentration-dependent manner and produced repetitive spike generation; ACh (up to 1 microM) did not modify the membrane potential. In thin muscle bundles, the above concentrations of NA hyperpolarized the membrane but ACh produced a large depolarization with repetitive spike generation. 5. In thick muscle bundles, nifedipine (0.3 microM) blocked twitch contractions generated spontaneously or provoked by application of NA with no effect on phasic and tonic responses. The NA-induced depolarization persisted after superfusion with nifedipine up to a concentration of 1.0 microM. In a Ca-free solution containing 2 mM EGTA, NA produced only the phasic responses, and re-addition of Ca (2.6 mM) restored the generation of a tonic response. 6. After application of 0.3 microM nifedipine, the effects of YM-12617 and prazosin were observed on the tonic component of the NA-induced contraction of thick muscle bundles. The ID50 values for YM-12617 and prazosin were 1 nM and 15 nM, respectively (n = 4). YM-12617 shifted the NA concentration-response curve to the right in a concentration-dependent and parallel manner. The Schild plot yielded a straight line with slope of 0.97 +/- 0.05, (n = 4). The pA2 value for YM-12617 was 10.4 +/- 0.05, (n = 4).(ABSTRACT TRUNCATED AT 400 WORDS)

Full text

PDF
702

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrams P. H., Shah P. J., Stone R., Choa R. G. Bladder outflow obstruction treated with phenoxybenzamine. Br J Urol. 1982 Oct;54(5):527–530. doi: 10.1111/j.1464-410x.1982.tb13581.x. [DOI] [PubMed] [Google Scholar]
  2. Bean B. P., Sturek M., Puga A., Hermsmeyer K. Calcium channels in muscle cells isolated from rat mesenteric arteries: modulation by dihydropyridine drugs. Circ Res. 1986 Aug;59(2):229–235. doi: 10.1161/01.res.59.2.229. [DOI] [PubMed] [Google Scholar]
  3. Bolton T. B. Mechanisms of action of transmitters and other substances on smooth muscle. Physiol Rev. 1979 Jul;59(3):606–718. doi: 10.1152/physrev.1979.59.3.606. [DOI] [PubMed] [Google Scholar]
  4. Boreham P. F., Braithwaite P., Milewski P., Pearson H. Alpha-adrenergic blockers in prostatism. Br J Surg. 1977 Oct;64(10):756–757. doi: 10.1002/bjs.1800641019. [DOI] [PubMed] [Google Scholar]
  5. Brooks M. E., Sidi A. A., Hanani Y., Braf Z. F. Ineffectiveness of phenoxybenzamine in treatment of benign prostatic hypertrophy. A controlled study. Urology. 1983 May;21(5):474–478. doi: 10.1016/0090-4295(83)90044-4. [DOI] [PubMed] [Google Scholar]
  6. Caine M., Perlberg S. Dynamics of acute retention in prostatic patient and role of adrenergic receptors. Urology. 1977 Apr;9(4):399–403. doi: 10.1016/0090-4295(77)90215-1. [DOI] [PubMed] [Google Scholar]
  7. Caine M., Perlberg S., Meretyk S. A placebo-controlled double-blind study of the effect of phenoxybenzamine in benign prostatic obstruction. Br J Urol. 1978 Dec;50(7):551–554. doi: 10.1111/j.1464-410x.1978.tb06210.x. [DOI] [PubMed] [Google Scholar]
  8. Caine M., Perlberg S., Shapiro A. Phenoxybenzamine for benign prostatic obstruction. Review of 200 cases. Urology. 1981 Jun;17(6):542–546. doi: 10.1016/0090-4295(81)90071-6. [DOI] [PubMed] [Google Scholar]
  9. Caine M., Raz S., Zeigler M. Adrenergic and cholinergic receptors in the human prostate, prostatic capsule and bladder neck. Br J Urol. 1975 Apr;47(2):193–202. doi: 10.1111/j.1464-410x.1975.tb03947.x. [DOI] [PubMed] [Google Scholar]
  10. Creed K. E., Ishikawa S., Ito Y. Electrical and mechanical activity recorded from rabbit urinary bladder in response to nerve stimulation. J Physiol. 1983 May;338:149–164. doi: 10.1113/jphysiol.1983.sp014666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dunzendorfer U., Jonas D., Weber W. The autonomic innervation of the human prostate. Histochemistry of acetylcholinesterase in the normal and pathologic states. Urol Res. 1976 Apr 21;4(1):29–31. doi: 10.1007/BF00256133. [DOI] [PubMed] [Google Scholar]
  12. Hashimoto T., Hirata M., Ito Y. A role for inositol 1,4,5-trisphosphate in the initiation of agonist-induced contractions of dog tracheal smooth muscle. Br J Pharmacol. 1985 Sep;86(1):191–199. doi: 10.1111/j.1476-5381.1985.tb09449.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hashimoto T., Hirata M., Itoh T., Kanmura Y., Kuriyama H. Inositol 1,4,5-trisphosphate activates pharmacomechanical coupling in smooth muscle of the rabbit mesenteric artery. J Physiol. 1986 Jan;370:605–618. doi: 10.1113/jphysiol.1986.sp015953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hedlund H., Andersson K. E., Ek A. Effects of prazosin in patients with benign prostatic obstruction. J Urol. 1983 Aug;130(2):275–278. doi: 10.1016/s0022-5347(17)51106-4. [DOI] [PubMed] [Google Scholar]
  15. Hedlund H., Andersson K. E., Larsson B. Alpha-adrenoceptors and muscarinic receptors in the isolated human prostate. J Urol. 1985 Dec;134(6):1291–1298. doi: 10.1016/s0022-5347(17)47714-7. [DOI] [PubMed] [Google Scholar]
  16. Hieble J. P., Caine M., Zalaznik E. In vitro characterization of the alpha-adrenoceptors in human prostate. Eur J Pharmacol. 1985 Jan 2;107(2):111–117. doi: 10.1016/0014-2999(85)90048-2. [DOI] [PubMed] [Google Scholar]
  17. Honda K., Miyata-Osawa A., Takenaka T. alpha 1-Adrenoceptor subtype mediating contraction of the smooth muscle in the lower urinary tract and prostate of rabbits. Naunyn Schmiedebergs Arch Pharmacol. 1985 Jul;330(1):16–21. doi: 10.1007/BF00586704. [DOI] [PubMed] [Google Scholar]
  18. Honda K., Nakagawa C. Alpha-1 adrenoceptor antagonist effects of the optical isomers of YM-12617 in rabbit lower urinary tract and prostate. J Pharmacol Exp Ther. 1986 Nov;239(2):512–516. [PubMed] [Google Scholar]
  19. Honda K., Takenaka T., Miyata-Osawa A., Terai M. Adrenoceptor blocking properties of the stereoisomers of amosulalol (YM-09538) and the corresponding desoxy derivative (YM-11133). J Pharmacol Exp Ther. 1986 Mar;236(3):776–783. [PubMed] [Google Scholar]
  20. Ito Y., Kimoto Y. The neural and non-neural mechanisms involved in urethral activity in rabbits. J Physiol. 1985 Oct;367:57–72. doi: 10.1113/jphysiol.1985.sp015814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lepor H., Shapiro E. Characterization of alpha1 adrenergic receptors in human benign prostatic hyperplasia. J Urol. 1984 Dec;132(6):1226–1229. doi: 10.1016/s0022-5347(17)50110-x. [DOI] [PubMed] [Google Scholar]
  22. Loirand G., Pacaud P., Mironneau C., Mironneau J. Evidence for two distinct calcium channels in rat vascular smooth muscle cells in short-term primary culture. Pflugers Arch. 1986 Nov;407(5):566–568. doi: 10.1007/BF00657519. [DOI] [PubMed] [Google Scholar]
  23. Raz S., Zeigler M., Caine M. Pharmacological receptors in the prostate. Br J Urol. 1973 Dec;45(6):663–667. doi: 10.1111/j.1464-410x.1973.tb12237.x. [DOI] [PubMed] [Google Scholar]
  24. Shapiro A., Mazouz B., Caine M. The alpha-adrenergic blocking effect of prazosin on the human prostate. Urol Res. 1981;9(1):17–20. doi: 10.1007/BF00256833. [DOI] [PubMed] [Google Scholar]
  25. Suematsu E., Hirata M., Hashimoto T., Kuriyama H. Inositol 1,4,5-trisphosphate releases Ca2+ from intracellular store sites in skinned single cells of porcine coronary artery. Biochem Biophys Res Commun. 1984 Apr 30;120(2):481–485. doi: 10.1016/0006-291x(84)91279-8. [DOI] [PubMed] [Google Scholar]
  26. Taira N. The autonomic pharmacology of the bladder. Annu Rev Pharmacol. 1972;12:197–208. doi: 10.1146/annurev.pa.12.040172.001213. [DOI] [PubMed] [Google Scholar]
  27. Takita T., Otani T., Kondo A., Mitsuya H. [Urodynamic study of the lower urinary tract. XII. The effect of prazosin hydrochloride in the treatment of prostatic obstruction and etiology of unstable bladder]. Nihon Hinyokika Gakkai Zasshi. 1983 Jan;74(1):1–14. [PubMed] [Google Scholar]
  28. Van Breemen C., Aaronson P., Loutzenhiser R. Sodium-calcium interactions in mammalian smooth muscle. Pharmacol Rev. 1978 Jun;30(2):167–208. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES